Edition:
United States

Sorrento Therapeutics Inc (SRNE.OQ)

SRNE.OQ on NASDAQ Stock Exchange Capital Market

7.55USD
23 May 2018
Change (% chg)

-- (--)
Prev Close
$7.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
726,041
52-wk High
$10.65
52-wk Low
$1.50

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

William Marth

61 2014 Independent Chairman of the Board

Henry Ji

63 2012 President, Chief Executive Officer, Director

Jiong Shao

49 2018 Chief Financial Officer, Executive Vice President

Kevin Herde

2018 Executive Vice President

Mike Royal

61 2014 Executive Vice President - Clinical and Regulatory Affairs